Endophthalmitis After Intravitreal Injection of Vascular Endothelial Growth Factor Inhibitors: Management & Visual Outcomes

被引：0
|
作者：
Xu, Kunyong [1 ]
Chin, Eric K. [2 ]
Almeida, David R. P. [3 ]
机构：
[1] Weill Cornell Med, Ophthalmol, New York, NY USA
[2] Retina Consultants Southern Calif, Redlands, CA USA
[3] VitreoRetinal Surg PA, Minneapolis, MN USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2018年 / 59卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
4425
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Systemic Immunosuppression and Risk of Endophthalmitis After Intravitreal Anti-Vascular Endothelial Growth Factor Injections
    Patel, Samir N.
    Storey, Philip P.
    Kim, Julie S.
    Obeid, Anthony
    Pancholy, Maitri
    Hsu, Jason
    Garg, Sunir J.
    OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2021, 52 (07): : S17 - S22
  • [32] Re: Xu et al.: Endophthalmitis after intravitreal injection of vascular endothelial growth factor inhibitors (Ophthalmology. 2018; 125: 1279-1286)
    Eldeeb, Mohab
    Hegazy, Omar
    Eldeeb, Mohamed Ali
    OPHTHALMOLOGY, 2018, 125 (11) : E80 - E81
  • [33] Endophthalmitis After Intravitreal Injection: Prevention and Management
    Wykoff, Charles C.
    Flynn, Harry W., Jr.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2011, 31 (04): : 633 - 635
  • [34] Computer-Based Visual Evaluation as a Screening Tool after Intravitreal Injections of Vascular Endothelial Growth Factor Inhibitors
    Meyer, Carsten H.
    Lapolice, Deborah J.
    OPHTHALMOLOGICA, 2008, 222 (06) : 364 - 368
  • [35] Impact of practice modifications on infectious endophthalmitis rates following intravitreal injection of anti-vascular endothelial growth factor
    Maloney, Maya
    Barkmeier, Andrew
    Bakri, Sophie J.
    Iezzi, Raymond
    Pulido, Jose
    Smith, Wendy
    Erie, Jay
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [36] POOLED ESTIMATES OF INCIDENCE OF ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTION OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR AGENTS WITH AND WITHOUT TOPICAL ANTIBIOTIC PROPHYLAXIS
    Reibaldi, Michele
    Pulvirenti, Alfredo
    Avitabile, Teresio
    Bonfiglio, Vincenza
    Russo, Andrea
    Mariotti, Cesare
    Bucolo, Claudio
    Mastropasqua, Rodolfo
    Parisi, Guglielmo
    Longo, Antonio
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2018, 38 (01): : 1 - 11
  • [37] Recurrent panuveitis after initial treatment of endophthalmitis secondary to intravitreal anti-vascular endothelial growth factor
    Shah, Saumya M.
    Barkmeier, Andrew J.
    Bakri, Sophie J.
    CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE, 2020, 55 (06): : E195 - E197
  • [38] Incidence and Visual Outcomes of Endophthalmitis After Intravitreal Injection of Dexamethasone Implant vs Ranibizumab
    Pancholy, Maitri
    Storey, Philip P.
    Wood, Edward H.
    Chaudhary, Varun
    Obeid, Anthony
    Marlow, Elizabeth
    Farley, Nathan D.
    Wolfe, Jeremy D.
    Garg, Sunir J.
    JOURNAL OF VITREORETINAL DISEASES, 2022, 6 (05) : 358 - 366
  • [39] Incidence of Endophthalmitis after Intravitreal Anti-Vascular Endothelial Growth Factor Injections in an Operating Room in China
    Chen, Yanyun
    Wei, Wenbin
    Vavvas, Demetrios G.
    Zhang, Feng
    She, Haicheng
    Zhou, Haiying
    Li, Lei
    Huang, Yao
    Ntentakis, Dimitrios P.
    Shi, Xiangyu
    JOURNAL OF OPHTHALMOLOGY, 2020, 2020
  • [40] Pituitary Apoplexy After Intravitreal Injection of Vascular Endothelial Growth Factor Inhibitor: A Novel Complication
    Kasl, Rebecca A.
    Kistka, Heather M.
    Turner, Justin H.
    Devin, Jessica K.
    Chambless, Lola B.
    JOURNAL OF NEUROLOGICAL SURGERY REPORTS, 2015, 76 (02) : E205 - E210
12345